Cargando…
Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam
Previous studies have demonstrated that pharmaceutical equivalence and pharmacokinetic equivalence of generic antibiotics are necessary but not sufficient conditions to guarantee therapeutic equivalence (better called pharmacodynamic equivalence). In addition, there is scientific evidence suggesting...
Autores principales: | Rodriguez, Carlos A., Agudelo, Maria, Aguilar, Yudy A., Zuluaga, Andres F., Vesga, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871539/ https://www.ncbi.nlm.nih.gov/pubmed/27191163 http://dx.doi.org/10.1371/journal.pone.0155806 |
Ejemplares similares
-
Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model
por: Zuluaga, Andres F., et al.
Publicado: (2010) -
Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis
por: Gonzalez, Javier M., et al.
Publicado: (2015) -
Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics
por: Zuluaga, Andres F, et al.
Publicado: (2009) -
In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin
por: Rodriguez, Carlos A, et al.
Publicado: (2010) -
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model
por: Zuluaga, Andres F., et al.
Publicado: (2015)